Fresenius Medical Care AG (Fresenius Medical Care AG) Change In Receivables : $-160 Mil (TTM As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Fresenius Medical Care AG Change In Receivables?

Fresenius Medical Care AG's change in receivables for the quarter that ended in Dec. 2023 was $-83 Mil. It means Fresenius Medical Care AG's Accounts Receivable increased by $83 Mil from Sep. 2023 to Dec. 2023 .

Fresenius Medical Care AG's change in receivables for the fiscal year that ended in Dec. 2023 was $-166 Mil. It means Fresenius Medical Care AG's Accounts Receivable increased by $166 Mil from Dec. 2022 to Dec. 2023 .

Fresenius Medical Care AG's Accounts Receivable for the quarter that ended in Dec. 2023 was $4,021 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Fresenius Medical Care AG's Days Sales Outstanding for the three months ended in Dec. 2023 was 67.45.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Fresenius Medical Care AG's liquidation value for the three months ended in Dec. 2023 was $-14,949 Mil.

Fresenius Medical Care AG Change In Receivables Historical Data

The historical data trend for Fresenius Medical Care AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Change In Receivables Chart

Fresenius Medical Care AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-71.23

87.22

-184.40

-49.45

-165.59

Fresenius Medical Care AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-3.98	-382.06	356.26	-51.24	-82.67

Fresenius Medical Care AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-160 Mil.

Fresenius Medical Care AG (NYSE:FMS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Fresenius Medical Care AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4020.736	/	5439.352	*	91
=	67.45

2. In Ben Graham's calculation of liquidation value, Fresenius Medical Care AG's accounts receivable are only considered to be worth 75% of book value:

Fresenius Medical Care AG's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1679.147	-	20832.359	+	0.75 * 4020.736	+	0.5 * 2376.418
=	-14,949

Fresenius Medical Care AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

FMCQF:USA FME:Italy FMEd:UK 0H9X:UK FME:Germany FMEA:Germany FME:Germany FME:Germany FMEA:Germany FME:Germany FMSC34:Brazil FME:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.freseniusmedicalcare.com

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

Executives

Helen Pring Giza

Board of Directors